Filing Details

Accession Number:
0001493152-25-009710
Form Type:
13G Filing
Publication Date:
2025-03-09 20:00:00
Filed By:
ABG Management Ltd.
Company:
Whitehawk Therapeutics Inc. (NASDAQ:WHWK)
Filing Date:
2025-03-10
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
ABG Management Ltd. 0 817,939 1.8%
Ally Bridge Group (NY) LLC 0 817,939 1.8%
Ally Bridge MedAlpha Master Fund L.P. 0 817,939 1.8%
ABG Innovation Capital Partners III GP Limited 0 26,666 0.1%
ABG Innovation Capital Partners III GP, L.P. 0 26,666 0.1%
Ally Bridge Group Innovation Capital Partners III, L.P. 0 26,666 0.1%
ABG Innovation-SO Limited 0 26,666 0.1%
ABG Global Life Science Capital Partners V GP Limited 0 2,070,000 4.5%
ABG Global Life Science Capital Partners V GP, L.P. 0 2,070,000 4.5%
Ally Bridge Group Global Life Science Capital Partners V, L.P. 0 2,070,000 4.5%
ABG-SIV, L.P. 0 2,070,000 4.5%
ABG V-SIV Limited 0 2,070,000 4.5%
Fan Yu 0 2,914,605 6.3%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
ABG Management Ltd.
 
Signature:By: /s/ Fan Yu
Name/Title:Fan Yu, Director
Date:03/10/2025
 
Ally Bridge Group (NY) LLC
 
Signature:By: ABG Management Ltd., its managing member, By: /s/ Fan Yu
Name/Title:Fan Yu, Director
Date:03/10/2025
 
Ally Bridge MedAlpha Master Fund L.P.
 
Signature:By: Ally Bridge Group (NY) LLC, its manager, By: ABG Management Ltd., its managing member, By: /s/ Fan Yu
Name/Title:Fan Yu, Director
Date:03/10/2025
 
ABG Innovation Capital Partners III GP Limited
 
Signature:By: /s/ Fan Yu
Name/Title:Fan Yu, Director
Date:03/10/2025
 
ABG Innovation Capital Partners III GP, L.P.
 
Signature:By: ABG Innovation Capital Partners III GP Limited, its general partner, By: /s/ Fan Yu
Name/Title:Fan Yu, Director
Date:03/10/2025
 
Ally Bridge Group Innovation Capital Partners III, L.P.
 
Signature:By: ABG Innovation Capital Partners III GP, L.P., its general partner, By: ABG Innovation Capital Partners III GP Limited, its general partner, By:
Name/Title:Fan Yu, Director
Date:03/10/2025
 
ABG Innovation-SO Limited
 
Signature:By: /s/ Shan-ju Yeh
Name/Title:Shan-ju Yeh, Director
Date:03/10/2025
 
ABG Global Life Science Capital Partners V GP Limited
 
Signature:By: /s/ Shan-ju Yeh
Name/Title:Shan-ju Yeh, Director
Date:03/10/2025
 
ABG Global Life Science Capital Partners V GP, L.P.
 
Signature:By: ABG Global Life Science Capital Partners V GP Limited, its general partner, By: /s/ Shan-ju Yeh
Name/Title:Shan-ju Yeh, Director
Date:03/10/2025
 
Ally Bridge Group Global Life Science Capital Partners V, L.P.
 
Signature:By: ABG Global Life Science Capital Partners V GP, L.P., its general partner, By: ABG Global Life Science Capital Partners V GP Limited, its general
Name/Title:Shan-ju Yeh, Director
Date:03/10/2025
 
ABG-SIV, L.P.
 
Signature:By: ABG Global Life Science Capital Partners V GP, L.P., its general partner, By: ABG Global Life Science Capital Partners V GP Limited, its general
Name/Title:Shan-ju Yeh, Director
Date:03/10/2025
 
ABG V-SIV Limited
 
Signature:By: /s/ Shan-ju Yeh
Name/Title:Shan-ju Yeh, Director
Date:03/10/2025
 
Fan Yu
 
Signature:/s/ Fan Yu
Name/Title:Fan Yu
Date:03/10/2025
Exhibit Information

99: Joint Filing Agreement.